The global mental health market is expected to be worth $560 billion by 2030, driven by an aging population and rising numbers of people with mental health disorders. By investing in mental health stocks, you can grow your portfolio while supporting companies that make and deliver treatments.
When you buy mental health stocks, you’re buying shares in publicly traded companies that deliver products or services related to the mental health industry. This includes creating treatments or medications, offering counselling services, producing educational materials and developing technology to assist mental healthcare professionals and clients.
Teladoc Health provides virtual healthcare services in the United States and internationally. Through the Teladoc, Livongo, and BetterHelp brands, it offers services for a wide range of conditions including diabetes, chronic kidney disease, cancer, congestive heart failure and mental health conditions.
Eli Lilly and Company discovers, develops and markets human pharmaceuticals worldwide. Its portfolio of products include treatments for depression, anxiety, schizophrenia, bipolar disorder, diabetes, cancer, arthritis, osteoporosis and other conditions. The company makes Prozac (fluoxetine), one of the most widely used FDA-approved antidepressants on the market.
Pfizer discovers, develops, manufactures, markets, distributes and sells a wide range of biopharmaceutical products worldwide. The company makes a number of widely used medications that treat mental health conditions including Xanax (alprazolam), Effexor (venlafaxine) and Zoloft (sertraline).
Talkspace is a New York based virtual behavior healthcare company that delivers healthcare services through encrypted web and mobile platform. The company offers treatment options for psychiatry therapy as well as adolescent, individual and couples therapy.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures and markets biopharmaceutical products worldwide including Abilify (Aripiprazole), an antipsychotic medication. It offers products for neuroscience, hematology, oncology, cardiovascular, immunology, fibrotic and covid-19 diseases.
Johnson & Johnson makes and sells healthcare products worldwide. Its brands include Johnson’s, Aveeno, Listerine, Neutrogena, Tylenol and Band-Aid. Its subsidiary, Janssen Pharmaceuticals, develops a number of treatments for mood disorders, neurodegenerative disorders and schizophrenia including Haldol (haloperidol), Risperdal (risperidone) and Invega (paliperidone).
Around 1 in 5 adults in the US have a mental health disorder, according to 2020 data released by the Substance Abuse and Mental Health Services Administration (SAMHSA). This is roughly 52.9 million people or 21% of the US adult population.
The data shows a higher rate of mental health disorders among females (25.8%) than males (15.8%). There was also a higher rate of mental health illness among young adults aged 18-25 (30.6%) than adults aged 26-49 (25.3%) or 50+ (14.5%).
Many conditions fall under the umbrella of mental health disorders including anxiety disorder, panic disorder, bipolar disorder, eating disorder, borderline personality disorder, depression, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), schizophrenia and trauma.
Mental health problems aren’t new, but they’re certainly starting to get more awareness, with several celebrities, including Ryan Reynolds, Beyoncé, and even Prince Harry coming out to talk about their own mental health. Increasing awareness may help convince people to seek help for their problems, thereby driving up demand for mental health services.
One of the main risks of investing in mental health stocks is that companies you don’t invest in will be quicker to come out with new treatments or technologies. For therapy stocks in companies that offer program-based treatments, there’s a risk that programs will become ineffective or that users will lose interest.
The mental health industry is growing as companies rise to meet the demands of a population increasingly challenged with mental health disorders. Investing in therapy stocks can support companies that deliver treatments or develop pharmaceuticals while diversifying your portfolio.
As with all investments, there are risks to investing in mental health stocks, so be sure to carefully research companies and stock trading platforms before you buy in.
These are the stocks to buy when you don’t have much to spend.
Read more…
Here are the 10 best gold stocks based on year-to-date returns for July 2024.
Read more…
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
Read more…
Check out our picks of the best paper trading platforms to practice trading and investing with fake money.
Learn the basics of put options: what they are, how they work and a few examples.
A deep dive into the highlights and limitations of Frec.
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
These are the best day trading platforms, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
What you need to know about investing in the leading indicator for the overall US stock market.
Check out our 7 ideas for how to invest $10K to maximize your money.
Check out the best-performing ETFs so far in 2024.
